BioSpace News Archive

Artiva Biotherapeutics, Inc., announced that it has joined Pledge 1%, a global movement that supports the integration of philanthropy into corporate culture by inspiring companies to donate 1% of product, equity, profit, or employee time to causes of their choice.

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 4, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2021 financial results and respond to questions from financial analysts during the call.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), announces that greater than 50% of patients expected to complete the ONWARD™ Phase 3 trial evaluating AD04 as a therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in persons with certain target genotypes related to the serotonin transporter and receptor genes have completed the full, 24-week, treatment period.

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced final results from the Phase 3 PSOARING 3 long-term extension study of its investigational product tapinarof, a 1% once daily, non-steroidal topical cream for the treatment of plaque psoriasis in adults.

Bristol Myers Squibb (NYSE: BMY) today announced that data from 19 company-sponsored scientific presentations are being shared at the European Academy of Dermatology and Venereology (EADV) 30th Anniversary Congress taking place September 29 – October 2, 2021.

Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications associated with Diabetes, today announced their company launch, and introduction of their flagship product, NaviDKD.

Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announce today their available services for the infused medications bamlanivimab and etesevimab, also known as BAM.

Olympus announced that Anthem Blue Cross Blue Shield, the second largest commercial health plan in the country, has updated their coverage policy to include the Spiration Valve System for patients suffering from severe emphysema, a form of COPD.

X-Nav Technologies is proud to announce that over 150,000 dental implants have been surgically placed using X-Guide® Dynamic 3D Navigation – a system designed to assist dental surgeons in achieving more accurate and less invasive dental implant results than freehand surgery.

The International Society for Heart and Lung Transplantation Academies have returned. The ISHLT Academies are standalone educational courses designed to improve and maintain the highest possible standards in the care of patients with advanced heart and lung disease.